Search research articles
Contact Us
Filters
Showing results (431-440 of 475) with videos related to
Page
of 48
Sort By:
Translational Psychiatry
|
September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry
|
May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Scientific Reports
|
August 9, 2017
Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression
Faranak Farzan, Sravya Atluri, Matthew Frehlich, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Psychiatry Research. Neuroimaging
|
April 28, 2021
White matter microstructure in youth at risk for serious mental illness: A comparative analysis
Mohammed K Shakeel, Stefanie Hassel, Andrew D Davis, et al.
Translational Psychiatry
|
October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
Chelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder
Smadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.
Translational Psychiatry
|
October 12, 2024
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study
Benjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report
Katharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Scientific Reports
|
September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
Anastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.
Page
of 48
Search research articles
Search
Showing results (431-440 of 475) with videos related to
Sort By:
Page
of 48
Translational Psychiatry
|
September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry
|
May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Scientific Reports
|
August 9, 2017
Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression
Faranak Farzan, Sravya Atluri, Matthew Frehlich, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Psychiatry Research. Neuroimaging
|
April 28, 2021
White matter microstructure in youth at risk for serious mental illness: A comparative analysis
Mohammed K Shakeel, Stefanie Hassel, Andrew D Davis, et al.
Translational Psychiatry
|
October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
Chelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder
Smadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.
Translational Psychiatry
|
October 12, 2024
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study
Benjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report
Katharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Scientific Reports
|
September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
Anastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.
Page
of 48